Landos Biopharma Public
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.
.png)
Industry:
PharmTech
Headquarters:
Blacksburg, Montgomery County, Virginia, United States
Founded Date:
2017